{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:00:28Z","timestamp":1775041228483,"version":"3.50.1"},"reference-count":26,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To explore the mechanisms that underlie the bleeding tendency in type 2A and 2B von Willebrand disease (VWD), we analyzed the mural thrombus generation process on a collagen surface under physiologic blood flow in a perfusion chamber using whole blood from these VWD patients. At a low shear rate (50 s\u22121), thrombus generation in all type 2A and 2B VWD patients was comparable to that of healthy controls. At a high shear rate (1500 s\u22121), thrombus generation was impaired in all type 2A patients, whereas that in type 2B VWD patients varied from normal to significantly defective, as judged by epifluorescence microscopy of thrombus surface coverage. However, in type 2B patients who showed normal thrombus generation at 1500 s\u22121, the height and volume of thrombi was significantly reduced, albeit with the normal surface coverage, compared with control thrombi, and von Willebrand factor (VWF) was poorly distributed within the type 2B thrombus mass when analyzed in detail by confocal laser scanning microscopy. Addition of purified VWF to patient blood completely reversed the defective spatial thrombus growth in type 2B VWD. Thus, our results confirm the impaired thrombus generation in type 2B VWD, which has never been demonstrable in previous in vitro soluble-phase platelet aggregation assays, and point to the critical function of larger VWF multimers in the proper spatial growth of mural thrombi under high shear rate conditions.<\/jats:p>","DOI":"10.1182\/blood-2002-03-0944","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T21:05:10Z","timestamp":1042664710000},"page":"915-920","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":41,"title":["Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions"],"prefix":"10.1182","volume":"101","author":[{"given":"Mitsuhiko","family":"Sugimoto","sequence":"first","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Matsui","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Mizuno","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuko","family":"Tsuji","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Miyata","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Matsuda","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Fujimura","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics and Blood Transfusion, Nara Medical University, Kashihara, Japan; the Division of Transfusion Medicine, National Cardiovascular Center, Suita, Osaka, Japan; and the Center for Molecular Medicine, Jichi Medical School, Kawachi-gun, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111610504661000_B1","first-page":"265","article-title":"The hemostatic plug.","volume":"14","author":"Sixma","year":"1977","journal-title":"Semin Hematol."},{"key":"2019111610504661000_B2","doi-asserted-by":"crossref","first-page":"22777","DOI":"10.1016\/S0021-9258(18)54418-5","article-title":"von Willebrand factor.","volume":"266","author":"Sadler","year":"1991","journal-title":"J Biol Chem."},{"key":"2019111610504661000_B3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1172\/JCI119195","article-title":"von Willebrand factor.","volume":"99","author":"Ruggeri","year":"1997","journal-title":"J Clin Invest."},{"key":"2019111610504661000_B4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02981974","article-title":"Functional property of von Willebrand factor under flowing blood.","volume":"75","author":"Sugimoto","year":"2002","journal-title":"Int J Hematol."},{"key":"2019111610504661000_B5","first-page":"296","article-title":"Decreased adhesion of platelets to subendothelium in von Willebrand's disease.","volume":"83","author":"Tschopp","year":"1974","journal-title":"J Lab Clin Med."},{"key":"2019111610504661000_B6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1055\/s-0038-1646758","article-title":"Defective adhesion of platelets to subendothelium in von Willebrand's disease and Bernard-Soulier syndrome.","volume":"39","author":"Baumgartner","year":"1978","journal-title":"Thromb Haemost."},{"key":"2019111610504661000_B7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease.","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost."},{"key":"2019111610504661000_B8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02981973","article-title":"Molecular genetics of type 2 von Willebrand disease.","volume":"75","author":"Fressinaud","year":"2002","journal-title":"Int J Hematol."},{"key":"2019111610504661000_B9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1172\/JCI116735","article-title":"Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.","volume":"92","author":"Murata","year":"1993","journal-title":"J Clin Invest."},{"key":"2019111610504661000_B10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0925-5710(95)00367-2","article-title":"Shear stress-induced platelet aggregation in various types of von Willebrand disease.","volume":"61","author":"Nakagawa-Nishimura","year":"1995","journal-title":"Int J Hematol."},{"key":"2019111610504661000_B11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI109795","article-title":"Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII\/von Willebrand factor in plasma and platelets.","volume":"65","author":"Ruggeri","year":"1980","journal-title":"J Clin Invest."},{"key":"2019111610504661000_B12","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1021\/bi00235a013","article-title":"Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli.","volume":"30","author":"Sugimoto","year":"1991","journal-title":"Biochemistry."},{"key":"2019111610504661000_B13","doi-asserted-by":"crossref","first-page":"18172","DOI":"10.1016\/S0021-9258(18)55251-0","article-title":"Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin: a model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib.","volume":"266","author":"Sugimoto","year":"1991","journal-title":"J Biol Chem."},{"key":"2019111610504661000_B14","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1016\/S0021-9258(19)50324-6","article-title":"Analysis of structure-function relationships in the platelet membrane glycoprotein Ib-binding domain of von Willebrand's factor by expression of deletion mutants.","volume":"268","author":"Sugimoto","year":"1993","journal-title":"J Biol Chem."},{"key":"2019111610504661000_B15","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood.V88.10.3854.bloodjournal88103854","article-title":"Role and initiation mechanism of the interaction of glycoprotein Ib with surface-immobilized von Willebrand factor in a solid-phase platelet cohesion process.","volume":"88","author":"Tsuji","year":"1996","journal-title":"Blood."},{"key":"2019111610504661000_B16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1055\/s-0038-1653837","article-title":"Calcium ion-dependent monoclonal antibody against human fibrinogen: preparation, characterization, and application to fibrinogen purification.","volume":"73","author":"Takabe","year":"1995","journal-title":"Thromb Haemost."},{"key":"2019111610504661000_B17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0037-1615133","article-title":"Comparative studies on the anti-platelet effects of a humanized anti-platelet glycoprotein IIb\/IIIa antibody (YM337) and ReoPro under flow conditions.","volume":"80","author":"Kuwahara","year":"1998","journal-title":"Thromb Haemost."},{"key":"2019111610504661000_B18","first-page":"48","article-title":"Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.","volume":"69","author":"Sugimoto","year":"1999","journal-title":"Int J Hematol."},{"key":"2019111610504661000_B19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/blood.V94.3.968.415a13_968_975","article-title":"Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow.","volume":"94","author":"Tsuji","year":"1999","journal-title":"Blood."},{"key":"2019111610504661000_B20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02368167","article-title":"Design and construction of a linear shear stress flow chamber.","volume":"21","author":"Usami","year":"1993","journal-title":"Ann Biomed Eng."},{"key":"2019111610504661000_B21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1182\/blood.V94.4.1149","article-title":"Cytosolic calcium changes in a process of platelet adhesion and cohesion on a von Willebrand factor-coated surface under flow conditions.","volume":"94","author":"Kuwahara","year":"1999","journal-title":"Blood."},{"key":"2019111610504661000_B22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/hq0202.104122","article-title":"Platelet shape changes and adhesion under high shear flow.","volume":"22","author":"Kuwahara","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2019111610504661000_B23","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1182\/blood.V95.12.3796","article-title":"Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation.","volume":"95","author":"Ajzenberg","year":"2000","journal-title":"Blood."},{"key":"2019111610504661000_B24","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1073\/pnas.86.10.3793","article-title":"von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.","volume":"86","author":"de Groot","year":"1989","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111610504661000_B25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/79639","article-title":"Von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule.","volume":"7","author":"Celikel","year":"2000","journal-title":"Nat Struct Biol."},{"key":"2019111610504661000_B26","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1182\/blood.V89.8.2766","article-title":"Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flow.","volume":"89","author":"Lankhof","year":"1997","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/3\/915\/1260949\/h80303000915.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/3\/915\/1260949\/h80303000915.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T22:37:47Z","timestamp":1622155067000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/3\/915\/88862\/Mural-thrombus-generation-in-type-2A-and-2B-von"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-03-0944","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}